Sitagliptin And Metformin Hydrochloride
Also sold as ZITUVIMET, ZITUVIMET XR, Sitagliptin and Metformin hydrochloride, Sitagliptin and metformin hydrochloride, Sitagliptin and Metformin Hydrochloride
Medicine summary · from official FDA labels · Oct 19, 2026
What it’s used for
1 INDICATIONS AND USAGE ZITUVIMET is a combination of sitagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, and metformin hydrochloride (HCl), a biguanide, indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. ( 1 ) Limitations of Use: ZITUVIMET is not recommended in patients with type 1 diabetes mellitus.
How to take it
Take ZITUVIMET orally twice daily with meals. ( 2.
Important warnings
Lactic Acidosis: See boxed warning . ( 5.
Common side effects
The following adverse reactions are also discussed elsewhere in the prescribing information: Lactic Acidosis [see Warnings and Precautions ( 5. 1 )] Pancreatitis [see Warnings and Precautions ( 5.
Interactions
Table 4 presents clinically significant drug interactions with ZITUVIMET: Table 4: Clinically Significant Drug Interactions with ZITUVIMET Carbonic Anhydrase Inhibitors Clinical Impact: Carbonic anhydrase inhibitors frequently cause a decrease in serum bicarbonate and induce non-anion gap, hyperchloremic metabolic acidosis.
If pregnant or breastfeeding
8.
Forms & strengths
100 MG Oral Tablet · 50 MG Oral Tablet · 25 MG Oral Tablet · 25 MG/ML Oral Solution
Questions to ask your doctor or pharmacist
- Is this the right medicine for my condition, and how long should I take it?
- What side effects should I watch for, and which need urgent attention?
- Does this interact with my other medicines, supplements, or alcohol?
- What should I do if I miss a dose or take too much?